Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
      • Quality

      Leveraging LLMs to Accelerate Drug Discovery for Life Sciences (Presented by Snowflake)

      , Industry Field Chief Technology Officer, Life Sciences, Snowflake
      Generative AI is accelerating our ability to understand all aspects of drug discovery, including predicting the 3D structures of proteins and visualizing how small molecules (ligands) bind to proteins, a crucial step to understanding the underlying causes for disease and developing cures.

      We'll demonstrate how to run the protein folding model from BioNeMo by NVIDIA using enterprise-grade data in Snowflake with Snowpark Container Services. Discover how to leverage protein embedding models to perform similarity search to find similar proteins, compare their structures, and analyze whether the sequence similarity resulted in structural similarity using Uniprot RAW embeddings made available by EMBL and the protT5 model for obtaining protein embeddings. Finally, see how a ligand can dock with the protein by leveraging BioNeMo's stable diffusion model, DiffDock. The output will be presented in a Python-based Streamlit app inside Snowflake leveraging the Biopython libraries and PyMOL.
      活动: GTC 24
      日期: March 2024
      话题: 生物学 - 生成式 AI
      NVIDIA 技术: BioNeMo
      行业: 医疗健康与生命科学
      级别: 中级技术
      语言: 英语
      所在地: